CD274 and neoplasm: Importantly, PDL‐1 can be also transported in tumor‐derived EVs and bind directly to PD‐1 receptors on T‐cells, suppressing their activation and inhibiting their killing activity [85, 86, 87, 88, 89, 90] (extended review [91]).